These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 2295804

  • 1. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
    Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW.
    J Immunol; 1990 Jan 15; 144(2):662-6. PubMed ID: 2295804
    [Abstract] [Full Text] [Related]

  • 2. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
    Levy O, Ooi CE, Elsbach P, Doerfler ME, Lehrer RI, Weiss J.
    J Immunol; 1995 May 15; 154(10):5403-10. PubMed ID: 7730641
    [Abstract] [Full Text] [Related]

  • 3. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
    Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW.
    J Immunol; 1992 Jan 15; 148(2):532-7. PubMed ID: 1729370
    [Abstract] [Full Text] [Related]

  • 4. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
    Elsbach P, Weiss J, Doerfler M, Shu C, Kohn F, Ammons WS, Kung AH, Meszaros KK, Parent JB.
    Prog Clin Biol Res; 1994 Jan 15; 388():41-51. PubMed ID: 7831373
    [Abstract] [Full Text] [Related]

  • 5. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z, Hong Z, Guo W, Xiaoyun G, Gengfa L, Yongning L, Guangxia X.
    Int Immunopharmacol; 2004 Apr 15; 4(4):527-37. PubMed ID: 15099530
    [Abstract] [Full Text] [Related]

  • 6. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A, McKinney CE, Rinaldi M, Zarlenga DS, Bannerman DD.
    Vet Microbiol; 2007 Nov 15; 125(1-2):80-90. PubMed ID: 17560054
    [Abstract] [Full Text] [Related]

  • 7. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
    Weiss J, Muello K, Victor M, Elsbach P.
    J Immunol; 1984 Jun 15; 132(6):3109-15. PubMed ID: 6373924
    [Abstract] [Full Text] [Related]

  • 8. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
    Ooi CE, Weiss J, Doerfler ME, Elsbach P.
    J Exp Med; 1991 Sep 01; 174(3):649-55. PubMed ID: 1875165
    [Abstract] [Full Text] [Related]

  • 9. [A study on bactericidal/permeability increasing protein (BPI) as a natural inhibitor of endotoxin].
    Zhou H.
    Zhonghua Shao Shang Za Zhi; 2001 Apr 01; 17(2):102-4. PubMed ID: 11876922
    [Abstract] [Full Text] [Related]

  • 10. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
    Weersink AJ, van Kessel KP, van den Tol ME, van Strijp JA, Torensma R, Verhoef J, Elsbach P, Weiss J.
    J Immunol; 1993 Jan 01; 150(1):253-63. PubMed ID: 7678030
    [Abstract] [Full Text] [Related]

  • 11. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS, Acton RD, Battafarano RJ, Uknis ME, Ratz CA, Johnston JW, Haseman JR, Gray BH, Dunn DL.
    J Surg Res; 1996 Jun 01; 63(1):44-8. PubMed ID: 8661170
    [Abstract] [Full Text] [Related]

  • 12. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.
    Mannion BA, Kalatzis ES, Weiss J, Elsbach P.
    J Immunol; 1989 Apr 15; 142(8):2807-12. PubMed ID: 2539411
    [Abstract] [Full Text] [Related]

  • 13. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Elsbach P, Weiss J.
    Immunobiology; 1993 Apr 15; 187(3-5):417-29. PubMed ID: 8330906
    [Abstract] [Full Text] [Related]

  • 14. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
    Leeuwenberg JF, Dentener MA, Buurman WA.
    J Immunol; 1994 May 15; 152(10):5070-6. PubMed ID: 7513728
    [Abstract] [Full Text] [Related]

  • 15. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J, Elsbach P, Shu C, Castillo J, Grinna L, Horwitz A, Theofan G.
    J Clin Invest; 1992 Sep 15; 90(3):1122-30. PubMed ID: 1522221
    [Abstract] [Full Text] [Related]

  • 16. Release of bactericidal/permeability-increasing protein in experimental endotoxemia and clinical sepsis. Role of tumor necrosis factor.
    von der Möhlen MA, van der Poll T, Jansen J, Levi M, van Deventer SJ.
    J Immunol; 1996 Jun 15; 156(12):4969-73. PubMed ID: 8648149
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI).
    Azuma M, Matsuo A, Fujimoto Y, Fukase K, Hazeki K, Hazeki O, Matsumoto M, Seya T.
    Biochem Biophys Res Commun; 2007 Mar 09; 354(2):574-8. PubMed ID: 17239348
    [Abstract] [Full Text] [Related]

  • 18. Structure/function studies of an endotoxin-neutralizing peptide derived from bactericidal/permeability-increasing protein.
    Wasiluk KR, Leslie DB, Vietzen PS, Mayo KH, Dunn DL.
    Surgery; 2004 Aug 09; 136(2):253-60. PubMed ID: 15300188
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A, Zarlenga DS, Bannerman DD.
    Am J Vet Res; 2007 Nov 09; 68(11):1151-9. PubMed ID: 17975968
    [Abstract] [Full Text] [Related]

  • 20. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
    Dentener MA, Von Asmuth EJ, Francot GJ, Marra MN, Buurman WA.
    J Immunol; 1993 Oct 15; 151(8):4258-65. PubMed ID: 8409400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.